- Home
- IIIN vs CMPX Comparison
IIIN vs CMPX Comparison
Compare IIIN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIIN
- CMPX
- Stock Information
- Founded
- IIIN 1953
- CMPX 2014
- Country
- IIIN United States
- CMPX United States
- Employees
- IIIN 929
- CMPX N/A
- Industry
- IIIN Steel/Iron Ore
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- IIIN Industrials
- CMPX Health Care
- Exchange
- IIIN Nasdaq
- CMPX Nasdaq
- Market Cap
- IIIN 745.7M
- CMPX 576.5M
- IPO Year
- IIIN N/A
- CMPX N/A
- Fundamental
- Price
- IIIN $38.01
- CMPX $3.65
- Analyst Decision
- IIIN
- CMPX Strong Buy
- Analyst Count
- IIIN 0
- CMPX 7
- Target Price
- IIIN N/A
- CMPX $14.71
- AVG Volume (30 Days)
- IIIN 83.6K
- CMPX 1.7M
- Earning Date
- IIIN 10-16-2025
- CMPX 11-11-2025
- Dividend Yield
- IIIN 2.92%
- CMPX N/A
- EPS Growth
- IIIN 53.01
- CMPX N/A
- EPS
- IIIN 1.59
- CMPX N/A
- Revenue
- IIIN $604,566,000.00
- CMPX N/A
- Revenue This Year
- IIIN $24.62
- CMPX N/A
- Revenue Next Year
- IIIN $7.01
- CMPX N/A
- P/E Ratio
- IIIN $24.17
- CMPX N/A
- Revenue Growth
- IIIN 9.44
- CMPX N/A
- 52 Week Low
- IIIN $22.49
- CMPX $1.27
- 52 Week High
- IIIN $41.64
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- IIIN 47.30
- CMPX 56.88
- Support Level
- IIIN $37.72
- CMPX $3.31
- Resistance Level
- IIIN $39.22
- CMPX $3.80
- Average True Range (ATR)
- IIIN 0.84
- CMPX 0.24
- MACD
- IIIN -0.08
- CMPX -0.01
- Stochastic Oscillator
- IIIN 15.14
- CMPX 70.51
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.